Cargando…

A prognostic score in histological node negative breast cancer.

Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement....

Descripción completa

Detalles Bibliográficos
Autores principales: Chevallier, B., Mosseri, V., Dauce, J. P., Bastit, P., Julien, J. P., Asselain, B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971289/
https://www.ncbi.nlm.nih.gov/pubmed/2328212
_version_ 1782134878055170048
author Chevallier, B.
Mosseri, V.
Dauce, J. P.
Bastit, P.
Julien, J. P.
Asselain, B.
author_facet Chevallier, B.
Mosseri, V.
Dauce, J. P.
Bastit, P.
Julien, J. P.
Asselain, B.
author_sort Chevallier, B.
collection PubMed
description Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.
format Text
id pubmed-1971289
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19712892009-09-10 A prognostic score in histological node negative breast cancer. Chevallier, B. Mosseri, V. Dauce, J. P. Bastit, P. Julien, J. P. Asselain, B. Br J Cancer Research Article Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis. Nature Publishing Group 1990-03 /pmc/articles/PMC1971289/ /pubmed/2328212 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Chevallier, B.
Mosseri, V.
Dauce, J. P.
Bastit, P.
Julien, J. P.
Asselain, B.
A prognostic score in histological node negative breast cancer.
title A prognostic score in histological node negative breast cancer.
title_full A prognostic score in histological node negative breast cancer.
title_fullStr A prognostic score in histological node negative breast cancer.
title_full_unstemmed A prognostic score in histological node negative breast cancer.
title_short A prognostic score in histological node negative breast cancer.
title_sort prognostic score in histological node negative breast cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971289/
https://www.ncbi.nlm.nih.gov/pubmed/2328212
work_keys_str_mv AT chevallierb aprognosticscoreinhistologicalnodenegativebreastcancer
AT mosseriv aprognosticscoreinhistologicalnodenegativebreastcancer
AT daucejp aprognosticscoreinhistologicalnodenegativebreastcancer
AT bastitp aprognosticscoreinhistologicalnodenegativebreastcancer
AT julienjp aprognosticscoreinhistologicalnodenegativebreastcancer
AT asselainb aprognosticscoreinhistologicalnodenegativebreastcancer
AT chevallierb prognosticscoreinhistologicalnodenegativebreastcancer
AT mosseriv prognosticscoreinhistologicalnodenegativebreastcancer
AT daucejp prognosticscoreinhistologicalnodenegativebreastcancer
AT bastitp prognosticscoreinhistologicalnodenegativebreastcancer
AT julienjp prognosticscoreinhistologicalnodenegativebreastcancer
AT asselainb prognosticscoreinhistologicalnodenegativebreastcancer